EcoDrugPlus

Heat Shock Protein 90, Alpha (Cytosolic), Class A Member 1, Tandem Duplicate 1

Ensembl ID : ENSTRUG00000012406
Gene Symbol: HSP90AA1.1
1 Cross references
330 Possible Orthologues:

Heat Shock Protein Hsp 90-Beta

Ensembl ID : ENSTRUG00000017978
Gene Symbol: LOC101076976
3 Cross references
339 Possible Orthologues:

High Mobility Group Protein B1

Ensembl ID : ENSTRUG00000004822
Gene Symbol: LOC101067170
4 Cross references
509 Possible Orthologues:

High Mobility Group-T Protein-Like

Ensembl ID : ENSTRUG00000024044
Gene Symbol: LOC101063630
3 Cross references
510 Possible Orthologues:

High Mobility Group-T Protein-Like

Ensembl ID : ENSTRUG00000031731
Gene Symbol: LOC115252562
2 Cross references
510 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSTRUG00000030936
Gene Symbol: HRH1
3 Cross references
186 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSTRUG00000007773
Gene Symbol: HRH2
3 Cross references
182 Possible Orthologues:

Histamine Receptor H2a

Ensembl ID : ENSTRUG00000010410
Gene Symbol: HRH2A
1 Cross references
189 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSTRUG00000005364
Gene Symbol: HDAC1
1 Cross references
255 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSTRUG00000016566
Gene Symbol: HDAC10
3 Cross references
181 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSTRUG00000006770
Gene Symbol: HDAC2
4 Cross references
209 Possible Orthologues:

Histone Deacetylase 3

Ensembl ID : ENSTRUG00000032750
Gene Symbol: HDAC3
3 Cross references
155 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).